which glp-1 agonists have cardiovascular benefit Receptor in the Rehabilitation of Patients with Heart Failure: Mechanisms, Clinical Evidence, and Future Perspectives Mechanisms by which GLP-1 agonists

10.1016/j.metabol.2024.156043 47 LoombaR.AbdelmalekM

The study authors are independent from the funders, they had full access to all the data (including statistical reports and tables), they are responsible for the integrity of the data and the accuracy of the data analysis, and they accept responsibility to submit for publication

Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial

These medications represent a significant advancement in care by helping to regulate blood sugar, reduce appetite, and support healthy weight loss

[DOI] [PubMed] [Google Scholar] 35.Huthmacher J.A., Meier J.J., Nauck M.A

However, a database analysis of nearly 200,000 individuals treated with GLP-1RAs for diabetes, obesity or both identified a discontinuation rate of 36.5% at 12 months (30)